NGT-110

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNGT-110
Drug Alias Nameextended neuroamides (Neurogate)NGT-110
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit modulators
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsNeuralgiaEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurogate Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurogate Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeuralgiaEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A